Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - live fowl adenovirus - misc. vaccines or anti sera - live fowl adenovirus vaccine-viral active 0.0 ml - immunotherapy - poultry chicks - up to 28 days old | chicks of vaccinated hens - homologous types of fowl adenovirus infe | inclusion body hepatitus

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - m. hyopneumoniae - inactivated whole cell culture; thiomersal - misc. vaccines or anti sera - m. hyopneumoniae - inactivated whole cell culture vaccine-general active 6000.0 ru/do; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - mycoplasma hyopneumoniae | vaccine | equine rotavirus | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - egg drop sydrome 76 virus strain bc 14; oil adjuvant - misc. vaccines or anti sera - egg drop sydrome 76 virus strain bc 14 vaccine-viral active 0.0 p; oil adjuvant oil other 0.0 p - immunotherapy - poultry layers (eggs for human consump) | caged layers | chickens | chooks | hen - avian haemagglutinating adenovirus | adenovirus | egg drop syndrome

Malta - engleză - Malta Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection - influenza vaccine (split virion, inactivated) 15 µg - vaccines

Uniunea Europeană - engleză - EMA (European Medicines Agency)

mcm vaccine b.v. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3, hepatitis b surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) produced in vero cells/ haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - vaccines - vaxelis (dtap-hb-ipv-hib) is indicated for primary and booster vaccination in infants and toddlers from the age of 6 weeks, against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib). the use of vaxelis should be in accordance with official recommendations.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

resilience biomanufacturing ireland limited - influenza vaccine (whole virion, inactivated) containing antigen of: a/vietnam/1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - vaccine - greasy pig - vaccine

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - vaccine - glassers - vaccine

Australia - engleză - Department of Health (Therapeutic Goods Administration)

emergent sales and marketing australia pty ltd - vaccinia virus, quantity: 100000000 pfu/ml - injection, powder for - excipient ingredients: sodium chloride; albumin; neomycin sulfate; mannitol; hepes; polymyxin b sulfate - acam2000 is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection in an officially declared outbreak.